| July-December
2001 |
|
PERCENT (%) RESISTANCE
TO SELECTED ANTIBIOTICS BY HOSPITAL
|
| |
| Acinetobacter spp |
| |
Ceftazidime (all clinical specimens) |
| |
Amikacin (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Imipenem (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Pseudomonas aeruginosa |
| |
Ceftazidime (all clinical specimens) |
| |
Amikacin (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Imipenem (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Enterobacter spp |
| |
Ceftazidime (all clinical specimens) |
| |
Tobramycin (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| S. aureus |
| |
MRSA (all clinical specimens) |
| |
MRSA to Gentamicin (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Klebsiella pneumoniae |
| |
Ceftazidime (all clinical specimens) |
| |
Cefoxitin (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Tobramycin (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Enterococci |
| |
Vancomycin (all clinical specimens) |
| |
Streptomycin (all clinical specimens) |
| |
Gentamicin (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| E. coli |
| |
Ciprofloxacin (all clinical specimens) |
| |
Nalidixic (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
|
|
DISTRIBUTION OF BACTERIAL SPECIES
|
| All clinical specimens |
| |
Bacterial species by hospital
(wards) |
| |
Bacterial species by hospital (ICU) |
| Blood isolates |
| |
Bacterial species by hospital
(wards) |
| |
Bacterial species by hospital
(ICU) |
| Blood cultures |
| |
Isolated microorganisms by
type of ward |
